Research Article
Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease
Table 2
Factors associated with metabolic syndrome by multivariate analysis.
| | Odds ratio | 95% confidence interval | P value |
| All subjects | | | | BMI | 1.272 | 1.258–1.285 | <0.001 | Age | 1.041 | 1.038–1.043 | <0.001 | ALT | 1.006 | 1.005–1.008 | <0.001 | GGT | 1.005 | 1.004–1.006 | <0.001 | Platelet | 1.002 | 1.001–1.002 | <0.001 | Fatty liver | 2.499 | 2.339–2.670 | <0.001 | Male gender | 3.005 | 2.811–3.214 | <0.001 | Females | | | | BMI | 1.311 | 1.288–1.335 | <0.001 | Age | 1.065 | 1.059–1.071 | <0.001 | ALT | 1.007 | 1.004–1.009 | <0.001 | GGT | 1.004 | 1.002–1.005 | <0.001 | Platelet | 1.001 | 1.001–1.002 | 0.002 | Fatty liver | 3.275 | 2.888–3.714 | <0.001 | Males | | | | BMI | 1.242 | 1.225–1.259 | <0.001 | Age | 1.032 | 1.029–1.035 | <0.001 | ALT | 1.006 | 1.004–1.008 | <0.001 | GGT | 1.005 | 1.004–1.007 | <0.001 | Platelet | 1.002 | 1.001–1.002 | <0.001 | Fatty liver | 2.205 | 2.040–2.384 | <0.001 |
|
|
BMI, body mass index; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase.
|